04:30 PM EDT, 08/08/2025 (MT Newswires) -- Rani Therapeutics ( RANI ) filed a registration statement Friday for the potential sale of up to $200 million of securities from time to time in one or more offerings.

The filing covers class A common shares, preferred stock, debt securities, and warrants.

The company said it plans to use the net proceeds for working capital and general corporate purposes.